|
| 36511370 | Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective study. | Br J Surg | 2023 |
| 37240646 | Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study). | J Clin Med | 2023 |
| 36551641 | Single Center Experience with a 4-Week <sup>177</sup>Lu-PSMA-617 Treatment Interval in Patients with Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2022 |
| 35406485 | Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study. | Cancers (Basel) | 2022 |
| 35610367 | Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study. | Br J Cancer | 2022 |
| 34084283 | <i>Ex vivo</i> analysis of DNA repair targeting in extreme rare cutaneous apocrine sweat gland carcinoma. | Oncotarget | 2021 |
| 34557799 | Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. | Lancet Reg Health Eur | 2021 |
| 34604070 | <i>Ex Vivo</i> Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell Carcinoma. | Front Oncol | 2021 |
| 34423228 | <i>STRN-ALK</i> Fusion-Positive Case of Breast Cancer With Response to Alectinib. | JCO Precis Oncol | 2021 |
| 32388277 | Image-based ex vivo drug screen to assess targeted therapies in recurrent thymoma. | Lung Cancer | 2020 |
| 33212793 | A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study. | Diagnostics (Basel) | 2020 |
| 32576176 | Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinoma. | BMC Cancer | 2020 |
| 32645560 | Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinoma. | Neoplasia | 2020 |
| 31704811 | Clonal Evolution of MEK/MAPK Pathway Activating Mutations in a Metastatic Colorectal Cancer Case. | Anticancer Res | 2019 |
| 27132299 | [Molecular pathologic diagnosis of lung cancer requires basic knowledge also from clinicians]. | Duodecim | 2016 |
| 26237904 | [Circulating cell-free DNA as biomarker for cancer *header*]. | Duodecim | 2015 |
| 23065478 | Introducing tissue microarrays to molecular pathology. | Clin Chem | 2012 |
| 18656560 | The correlation between cellular size and protein expression levels--normalization for global protein profiling. | J Proteomics | 2008 |
| 17549799 | A high-throughput strategy for protein profiling in cell microarrays using automated image analysis. | Proteomics | 2007 |
| 16404366 | Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. | Br J Cancer | 2006 |
| 15169792 | Signal transducer and activator of transcription-5 activation and breast cancer prognosis. | J Clin Oncol | 2004 |
| 15542802 | Prevalence of KIT expression in human tumors. | J Clin Oncol | 2004 |
| 15248910 | [Analysis of gene expression profiles among 3 epithelial ovarian tumor subtypes using cDNA and tissue microarrays]. | Ai Zheng | 2004 |
| 14996721 | Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. | Cancer Res | 2004 |
| 12727846 | POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. | Cancer Res | 2003 |
| 12845634 | Cyclin E overexpression and amplification in human tumours. | J Pathol | 2003 |
| 11818019 | Morphological spot counting from stacked images for automated analysis of gene copy numbers by fluorescence in situ hybridization. | J Biomed Opt | 2002 |
| 12466114 | Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. | Am J Pathol | 2002 |
| 12107091 | High-throughput copy number analysis of 17q23 in 3520 tissue specimens by fluorescence in situ hybridization to tissue microarrays. | Am J Pathol | 2002 |
| 12094328 | A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. | Am J Hum Genet | 2002 |
| 11888886 | Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. | Cancer Res | 2002 |
| 11159196 | CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A. | Am J Pathol | 2001 |
| 11257096 | Tissue microarray technology for high-throughput molecular profiling of cancer. | Hum Mol Genet | 2001 |
| 11207349 | Gene-expression profiles in hereditary breast cancer. | N Engl J Med | 2001 |
| 11331760 | Comprehensive copy number and gene expression profiling of the 17q23 amplicon in human breast cancer. | Proc Natl Acad Sci U S A | 2001 |
| 11287641 | ANX7, a candidate tumor suppressor gene for prostate cancer. | Proc Natl Acad Sci U S A | 2001 |
| 11668471 | Tissue microarrays (TMAs) for high-throughput molecular pathology research. | Int J Cancer | 2001 |
| 11564899 | CGH, cDNA and tissue microarray analyses implicate FGFR2 amplification in a small subset of breast tumors. | Anal Cell Pathol | 2001 |
| 11733374 | Tissue microarrays for rapid linking of molecular changes to clinical endpoints. | Am J Pathol | 2001 |
| 11687967 | Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. | Oncogene | 2001 |
| 11439368 | Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. | J Pathol | 2001 |
| 11481385 | Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. | J Natl Cancer Inst | 2001 |
| 11066078 | Chromosome imbalances in familial gliomas detected by comparative genomic hybridization. | Genes Chromosomes Cancer | 2000 |
| 10980118 | High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. | Am J Pathol | 2000 |
| 10922410 | Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. | J Natl Cancer Inst | 2000 |
| 11085535 | Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. | Cancer Res | 2000 |
| 11034067 | Multiple genes at 17q23 undergo amplification and overexpression in breast cancer. | Cancer Res | 2000 |
| 11118044 | Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. | Cancer Res | 2000 |
| 11156738 | Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. | Cancer Genet Cytogenet | 2000 |
| 10567404 | A nuclear factor, ASC-2, as a cancer-amplified transcriptional coactivator essential for ligand-dependent transactivation by nuclear receptors in vivo. | J Biol Chem | 1999 |